Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Editat de Nima Rezaei, Mahsa Keshavarz-Fathien Limba Engleză Paperback – 21 oct 2018
- Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer
- Presents the status of past and current vaccines for cancer treatment
- Considers advantages and disadvantages of different therapeutic cancer vaccines
- Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods
- Analyzes obstacles to development of therapeutic cancer vaccines
- Gives a view on future perspectives in the application of therapeutic cancer vaccines
Preț: 640.02 lei
Preț vechi: 1007.34 lei
-36% Nou
Puncte Express: 960
Preț estimativ în valută:
122.50€ • 127.67$ • 101.97£
122.50€ • 127.67$ • 101.97£
Carte tipărită la comandă
Livrare economică 30 decembrie 24 - 13 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128140390
ISBN-10: 0128140399
Pagini: 198
Dimensiuni: 191 x 235 mm
Greutate: 0.35 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128140399
Pagini: 198
Dimensiuni: 191 x 235 mm
Greutate: 0.35 kg
Editura: ELSEVIER SCIENCE
Public țintă
Interdisciplinary: clinicians, scientists and researchers working on applying different modalities for cancer treatment, including biological therapies; immunologists, oncologists, biotechnologists, and other specialists dealing with cancer research and therapyCuprins
1. Cancer immunology 2. Immunotherapeutic Approaches in Cancer 3. Vaccines, Adjuvants, and Delivery Systems 4. Tumor Antigens 5. Strategy of Allogeneic and Autologous Cancer Vaccines 6. Personalized Cancer Vaccine 7. Whole Tumor Cell Vaccine for Cancer 8. Peptide and Protein Vaccines for Cancer 9. Immune Cell Vaccine for Cancer 10. Genetic Vaccine for Cancer 11. Candidate Cancers for Vaccination 12. Obstacles in the Development of Therapeutic Cancer Vaccines 13. Combination Therapy: Cancer Vaccines and Other Therapeutics 14. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines